Do print ads touting a prescription drug as “new” or “#1 prescribed” impact consumer perceptions of a product? That’s the question FDA aims to answer in its latest study of direct-to-consumer Rx drug advertising.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?